Subscapularis Repair Augmentation for Total Shoulder Arthroplasty
Launched by STANFORD UNIVERSITY · Aug 1, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a procedure for patients who are having total shoulder surgery, specifically looking at how well the shoulder tissue known as the subscapularis heals. The researchers want to compare two methods: a standard repair technique and a new approach that uses a special material called a Biobrace. They will use ultrasound imaging to see how well each method works and if there are any differences in how patients recover.
If you are between 65 and 74 years old and are scheduled for total shoulder arthroplasty (shoulder replacement surgery), you may be eligible to participate in this study. During the trial, participants will receive either the standard repair or the Biobrace method, and the team will monitor their healing process. It's important to note that the trial is currently recruiting participants, and individuals from all genders can join as long as they meet the eligibility criteria. This study aims to find out which method may offer better recovery for patients undergoing shoulder surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Total Shoulder Arthroplasty
- Exclusion Criteria:
- • Vulnerable population
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Orleans, Louisiana, United States
Redwood City, California, United States
Patients applied
Trial Officials
Michael T Freehill, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials